Congenica founders celebrate a decade of life-changing answers
Soon available on-demand
Ten years ago, a group of experts came together to realise a shared vision – that every patient should be afforded the benefits of next-generation sequencing (NGS). Combining business expertise with research from the Wellcome Trust Sanger Institute, NHS clinicians and genetic testing laboratories, Congenica was born.
On 23rd May 2023, as Congenica celebrates its first decade in business, we welcomed four of our founders and our CEO to a very special webinar focusing on their work over the past ten years. From major breakthrough projects and development of new genetic technologies, to how these translate into clinical applications and are transforming healthcare practices, the speakers have helped to deliver life-changing benefits to patients around the world.
Register to receive a recording of our celebratory webinar that covered some of the significant achievements of the past 10 years and how these are helping to drive precision medicine at scale.
- From 1000 Genomes to UK10K: The power and challenges of large-scale national programs
Professor Richard Durbin, Professor of Genetics at University of Cambridge and Informatics Director at Congenica
- Deciphering Developmental Disorders
Professor Matt Hurles, Director of the Wellcome Sanger Institute and Scientific Director at Congenica
- Transforming lives and healthcare
Professor Phil Beales, CEO at Axovia Therapeutics and Chief Medical Officer at Congenica
- Ending the diagnostic odyssey - where next? Navigating the translational roadmap towards new therapies for rare diseases
Professor Nick Lench, Executive Director, MRC/UKRI NATA and member of Congenica’s Scientific Advisory Board
- Driving Precision Medicine at scale
Robert Denison, CEO at Congenica